Quick Answer
Vanda Pharmaceuticals Inc. reported Stockholders Equity of $327.19 million for the year ending 2025.
- Vanda Pharmaceuticals Inc. showed a decrease of -39.2% in Stockholders Equity from 2024 to 2025.
- This data is from Vanda Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $20.98 million | Q2 2014: $885.0 thousand | Q3 2014: $1.06 million | Q1 2015: $152.47 million | Q2 2015: $149.75 million | Q3 2015: $145.94 million | Q1 2016: $123.01 million | Q2 2016: $121.61 million | Q3 2016: $129.17 million | Q1 2017: $128.14 million | Q2 2017: $131.42 million | Q3 2017: $130.47 million | Q1 2018: $241.14 million | Q2 2018: $251.27 million | Q3 2018: $261.42 million | Q1 2019: $278.41 million | Q2 2019: $296.69 million | Q3 2019: $400.91 million | Q1 2020: $416.39 million | Q2 2020: $431.58 million | Q3 2020: $440.57 million | Q1 2021: $467.63 million | Q2 2021: $481.22 million | Q3 2021: $493.32 million | Q1 2022: $502.12 million | Q2 2022: $508.55 million | Q3 2022: $515.66 million | Q1 2023: $535.74 million | Q2 2023: $539.90 million | Q3 2023: $543.10 million | Q1 2024: $544.00 million | Q2 2024: $542.52 million | Q3 2024: $541.22 million | Q1 2025: $511.42 million | Q2 2025: $486.33 million | Q3 2025: $466.00 million.
- Over the full 14 years of available data (2012 to 2025), Vanda Pharmaceuticals Inc.'s Stockholders Equity has grown by 3,203.2%.
- Historical annual values: Fiscal year 2025: $327.19 million | Fiscal year 2024: $538.55 million | Fiscal year 2023: $544.91 million | Fiscal year 2022: $527.20 million | Fiscal year 2021: $504.93 million | Fiscal year 2020: $453.27 million | Fiscal year 2019: $410.95 million | Fiscal year 2018: $275.42 million | Fiscal year 2017: $131.39 million | Fiscal year 2016: $131.33 million | Fiscal year 2015: $133.03 million | Fiscal year 2014: $160.82 million | Fiscal year 2013: $44.12 million | Fiscal year 2012: $9.91 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: